Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-01

FDA Approved: LAMOTRIGINE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves the original abbreviated new drug application for lamotrigine from Zydus Pharmaceuticals USA Inc., making a generic version available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

ORIG AP for LAMOTRIGINE (LAMOTRIGINE)